PBYI
Price
$4.86
Change
-$0.10 (-2.02%)
Updated
May 3, 6:59 PM EST
89 days until earnings call
VIR
Price
$10.39
Change
+$1.21 (+13.18%)
Updated
May 3, 6:59 PM EST
89 days until earnings call
Ad is loading...

Compare trend and price PBYI vs VIR

Header iconPBYI vs VIR Comparison
Open Charts PBYI vs VIRBanner chart's image
Puma Biotechnology
Price$4.86
Change-$0.10 (-2.02%)
Volume$212.79K
CapitalizationN/A
Vir Biotechnology
Price$10.39
Change+$1.21 (+13.18%)
Volume$992.6K
CapitalizationN/A
View a ticker or compare two or three
PBYI vs VIR Comparison Chart

Loading...

PBYIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
PBYI vs. VIR commentary
May 05, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBYI is a Hold and VIR is a StrongSell.

COMPARISON
Comparison
May 05, 2024
Stock price -- (PBYI: $4.86 vs. VIR: $10.39)
Brand notoriety: PBYI and VIR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBYI: 76% vs. VIR: 184%
Market capitalization -- PBYI: $234.44M vs. VIR: $1.41B
PBYI [@Biotechnology] is valued at $234.44M. VIR’s [@Biotechnology] market capitalization is $1.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $559.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBYI’s FA Score shows that 1 FA rating(s) are green whileVIR’s FA Score has 0 green FA rating(s).

  • PBYI’s FA Score: 1 green, 4 red.
  • VIR’s FA Score: 0 green, 5 red.
According to our system of comparison, both PBYI and VIR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBYI’s TA Score shows that 3 TA indicator(s) are bullish while VIR’s TA Score has 4 bullish TA indicator(s).

  • PBYI’s TA Score: 3 bullish, 4 bearish.
  • VIR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, PBYI is a better buy in the short-term than VIR.

Price Growth

PBYI (@Biotechnology) experienced а -3.19% price change this week, while VIR (@Biotechnology) price change was +26.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

PBYI is expected to report earnings on Aug 01, 2024.

VIR is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for PBYI with price predictions.
OPEN
A.I.dvisor published
a Summary for VIR with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
VIR($1.41B) has a higher market cap than PBYI($234M). PBYI YTD gains are higher at: 12.240 vs. VIR (3.280).
PBYIVIRPBYI / VIR
Capitalization234M1.41B17%
EBITDAN/AN/A-
Gain YTD12.2403.280373%
P/E Ratio10.80N/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
PBYI: Fundamental Ratings
PBYI
OUTLOOK RATING
1..100
19
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
18
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PBYIVIR
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
85%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 10 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
PBYIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VIRDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WCMIX24.480.34
+1.41%
WCM Focused International Growth Instl
RCMPX15.770.20
+1.28%
Lazard International Quality Gr R6
JGQIX15.640.19
+1.23%
Jensen Global Quality Growth I
PSIJX8.590.10
+1.18%
Principal SmallCap Growth I J
ATWCX20.680.24
+1.17%
AB Tax-Managed Wealth Apprec Strat C

PBYI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBYI
1D Price
Change %
PBYI100%
-2.02%
MDGL - PBYI
34%
Loosely correlated
+6.38%
VNDA - PBYI
33%
Loosely correlated
+4.27%
ORMP - PBYI
31%
Poorly correlated
+0.43%
AVRO - PBYI
30%
Poorly correlated
-0.81%
VIR - PBYI
29%
Poorly correlated
+13.18%
More

VIR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VIR has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if VIR jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VIR
1D Price
Change %
VIR100%
+13.18%
AXON - VIR
47%
Loosely correlated
+0.57%
GOSS - VIR
43%
Loosely correlated
-4.06%
MORF - VIR
38%
Loosely correlated
+4.14%
MDGL - VIR
36%
Loosely correlated
+6.38%
NTLA - VIR
36%
Loosely correlated
+1.42%
More